Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
| ▸ | GSR | P00390 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL3052910 | 0.98 | SLC1A5 (0.35) | SLC1A5SLC1A1GSRPTGS1SLC7A11 | |
| Serine SCHEMBL5271395 | 0.97 | SLC1A5 (0.34) | SLC1A5SLC1A1GSRIDO1 | |
| Serine SCHEMBL12500457 | 0.95 | SLC1A5 (0.33) | SLC1A5SLC1A1GSRGRIK1GRIK2 | |
| SCHEMBL16678086 | 0.93 | SLC1A5 (0.36) | SLC1A5SLC1A1GSRPTGS1SLC7A11 | |
| SCHEMBL5272389 | 0.91 | SLC1A5 (0.33) | SLC1A5SLC1A1IDO1NOS3NOS1 | |
| Glutamic Acid SCHEMBL9617054 | 0.90 | GRM8 (0.49) | SLC1A1GSRGRIK1GRIK2 | |
| Serine SCHEMBL7925097 | 0.90 | SLC1A5 (0.42) | SLC1A5SLC1A1GSRPTGS1SLC7A11 | |
| Serine SCHEMBL15094110 | 0.89 | SLC1A5 (0.38) | SLC1A5SLC1A1GSRPTGS1SLC7A11 | |
| Serine SCHEMBL3821533 | 0.89 | SLC1A5 (0.38) | SLC1A5SLC1A1GSRPTGS1SLC7A11 | |
| Glycine SCHEMBL12500492 | 0.88 | SLC1A5 (0.36) | SLC1A5SLC1A1GSRPTGS1SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295947-A | Multilabelled polymer constructs for detection assays | 剑桥分子诊断有限责任公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-101384279-B | Anti-amyloid immunogenic compositions, methods and uses | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-02-22 | — | — | CN | disclosed |
| US-7531317-B2 | Fluorescence polarization assay to detect protease cleavage | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-05-12 | — | — | US | disclosed |
| CN-101384279-A | Anti-amyloid immunogenic compositions, methods and uses | CHIESI FARMA SPA (IT) | 2009-03-11 | — | — | CN | disclosed |
| US-7456252-B2 | Therapeutic peptides for demyelinating conditions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-11-25 | — | — | US | disclosed |
| US-20060020109-A1 | Therapeutic peptides for demyelinating conditions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2006-01-26 | — | — | US | disclosed |
| US-20050227306-A1 | Fluorescence polarization assay to detect protease cleavage | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2005-10-13 | — | — | US | disclosed |
| US-6930168-B2 | Synthetic peptides for demyelinating conditions | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-08-16 | — | — | US | disclosed |
| EP-0773996-B1 | INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF | UNIV DUNDEE (GB) | 2004-12-15 | — | — | EP | disclosed |
| US-20030064915-A1 | Therapeutic peptides for demyelinating conditions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-03 | — | — | US | disclosed |
| WO-2002072753-A2 | THYMIDYLATE SYNTHASE PEPTIDES THAT BIND TO THYMIDYLATE SYNTHASE MESSENGER RNA | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2002-09-19 | — | — | WO | disclosed |
| WO-2002059143-A2 | THERAPEUTIC PEPTIDES FOR DEMYELINATING CONDITIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6153391-A | CONTACTING P53 AND ONCOPROTEIN WITH A PEPTIDE FRAGMENT OR ANALOGUE INCLUDING A DEFINED AMINO ACID SEQUENCE OR AN ORGANIC MOLECULE HAVING THREE-DIMENSIONAL STRUCTURE OF THAT AMINO ACID SEQUENCE; INTERFERES WITH BINDING | UNIVERSITY OF DUNDEE (GB) | 2000-11-28 | — | — | US | disclosed |
| US-5770377-A | DETECTING AND PREVENTING DEACTIVATION OF TUMOR SUPPRESSORS OR ANTICARCINOGENIC AGENTS | UNIVERSITY OF DUNDEE (GB) | 1998-06-23 | — | — | US | disclosed |
| US-5702908-A | MIXING LABELED FIRST PROTEIN AND SECOND PROTEIN INCLUDING MDM2 AND FRAGMENT OF HUMAN P35, ADDING TEST COMPOUND, DETERMINING QUANTITY OF BOUND PROTEIN WITH AND WITHOUT ADDED COMPOUND, WHEREIN DECREASE INDICATES BINDING INTERFERENCE | UNIVERSITY OF DUNDEE (GB) | 1997-12-30 | — | — | US | disclosed |
| EP-0773996-A1 | INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF | UNIVERSITY OF DUNDEE (GB) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996002642-A1 | INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF | UNIVERSITY OF DUNDEE (GB) | 1996-02-01 | — | — | WO | disclosed |